DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Chang L, Ameen VZ, Dukes GE. et al
A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Am J Gastroenterol 2005; 100: 115-123
We do not assume any responsibility for the contents of the web pages of other providers.